D. Boral Capital initiated coverage on Tevogen Bio with a new price target

3/4/25 8:26:08 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

D. Boral Capital initiated coverage of Tevogen Bio with a rating of Buy and set a new price target of $10.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TVGN

Date	Price Target	Rating	Analyst
3/4/2025	$10.00	Buy	D. Boral Capital